Bayer/Economist Report Identifies US$179bn Self-Care Opportunity for Supplements
A new report from Bayer and Economist Enterprise highlights the significant economic and health system benefits of integrated self-care, positioning supplements as a critical component. Industry must leverage this validation to drive market penetration and regulatory alignment.
London, United Kingdom — 22 May 2024
A recent report, 'Making self-care work: integrating self-care into health systems,' produced collaboratively by Bayer and Economist Enterprise, underscores the substantial economic and societal benefits of self-care. The publication attributes approximately US$179 billion in annual economic benefits to effective self-care practices, arguing for its critical role in reducing pressure on strained healthcare systems. This analysis explicitly includes dietary supplements as a core component of the self-care spectrum, alongside healthy behaviours, preventative measures, digital health tools, over-the-counter medicines, and self-monitoring.
The report's release comes amid increasing global healthcare challenges, including an aging demographic, a rise in chronic disease prevalence, and persistent workforce shortages. These factors collectively drive an elevated demand for health interventions, which, according to Bayer, can be partially alleviated through a more integrated approach to self-care. By promoting accessible and effective self-care solutions, countries can improve health outcomes and advance towards universal health coverage.
For the supplement industry, this report offers significant validation from a major pharmaceutical entity and a respected economic analysis firm. This external endorsement can be strategically leveraged by manufacturers and brand owners to advocate for greater recognition within national health policies, procurement discussions, and consumer education initiatives. The explicit inclusion of supplements provides a robust foundation for positioning products not merely as elective wellness items but as integral tools for public health and economic efficiency.
What this means for United Kingdom
UK supplement manufacturers and brand owners can capitalise on this report to strengthen engagement with the Department of Health and Social Care (DHSC) and the NHS. The US$179 billion economic benefit cited provides a powerful data point for advocating for increased public health messaging supporting supplements for preventative care, potentially influencing NHS procurement strategies for specific products. Businesses should prepare for potential increased regulatory scrutiny as the sector gains further visibility, ensuring MHRA and FSA compliance. Opportunities exist for brands aligned with chronic disease management or healthy aging, specifically in formulation and marketing towards these validated self-care pathways, potentially through Boots or Holland & Barrett channels.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.